Replies to post #77002 on Savvy Trades and Investments

[swampboots]

You are 100% correct, but this board measures a stock whose value adjusts to what it is worth if it went private and Co. had to depend entirely on its cash flow bottom line net..

[wadegarret]

dude, valuation is based on fully diluted

share count, not the float. The company will have to make $30M/year Net Income to be worth where the stock is now IMO. That may never happen. Biotechs with one drug hopeful are the riskiest of all plays.